SANDOZ GENTAMICIN DIN 02229440
Status: Cancelled Post Market
Holder: SANDOZ CANADA INCORPORATED
Molecule: GENTAMICIN (GENTAMICIN SULFATE)
Health Canada record
| Active ingredient(s) | GENTAMICIN (GENTAMICIN SULFATE) 3 MG |
|---|---|
| Dosage form | Liquid |
| Route | Ophthalmic |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | S01AA11 GENTAMICIN |
| Original market date | 07-Mar-1997 |
| Current status date | 01-Aug-2017 |
| Source | Health Canada DPD |
Establishment licence of the holder
Sandoz Canada Incorporated — licence 101370, currently licensed, last inspection rating C (2025-02-25).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing GENTAMICIN (GENTAMICIN SULFATE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02023776 | GENTAMICIN | STERI-MED PHARMA INC. | Ointment | GENTAMICIN (GENTAMICIN SULFATE) 0.3 % | Approved |
| 02242652 | GENTAMICIN INJECTION USP | SANDOZ CANADA INCORPORATED | Solution | GENTAMICIN (GENTAMICIN SULFATE) 40 MG | Marketed |
| 02470462 | GENTAMICIN INJECTION USP | HIKMA CANADA LIMITED | Solution | GENTAMICIN (GENTAMICIN SULFATE) 10 MG | Marketed |
| 02457008 | GENTAMICIN INJECTION USP | HIKMA CANADA LIMITED | Solution | GENTAMICIN (GENTAMICIN SULFATE) 40 MG | Marketed |
| 02268531 | GENTAMICIN INJECTION USP | SANDOZ CANADA INCORPORATED | Solution | GENTAMICIN (GENTAMICIN SULFATE) 10 MG | Marketed |
| 02082152 | GENTAMICIN(E) | BAXTER CORPORATION | Solution | GENTAMICIN (GENTAMICIN SULFATE) 1.6 MG | Marketed |
| 02082136 | GENTAMICIN(E) | BAXTER CORPORATION | Solution | GENTAMICIN (GENTAMICIN SULFATE) 1 MG | Marketed |
| 00592293 | GENTOCIN | INTERVET CANADA CORP | Solution | GENTAMICIN (GENTAMICIN SULFATE) 100 MG | Marketed |
| 02344688 | MOMETAMAX | INTERVET CANADA CORP | Suspension | GENTAMICIN (GENTAMICIN SULFATE) 3 MG; MOMETASONE FUROATE (MOMETASONE FUROATE MONOHYDRATE) 1 MG; CLOTRIMAZOLE 10 MG | Marketed |
| 00817112 | OTOMAX | INTERVET CANADA CORP | Ointment | GENTAMICIN (GENTAMICIN SULFATE) 3 MG; CLOTRIMAZOLE 10 MG; BETAMETHASONE (BETAMETHASONE VALERATE) 1.0 MG | Marketed |
| 00602841 | TOPAGEN | INTERVET CANADA CORP | Spray | GENTAMICIN (GENTAMICIN SULFATE) 0.57 MG; BETAMETHASONE (BETAMETHASONE VALERATE) 0.284 MG | Marketed |
| 00436771 | ALCOMICIN OPH SOL 3MG/ML | ALCON CANADA INC | Liquid | GENTAMICIN (GENTAMICIN SULFATE) 3 MG | Cancelled Post Market |
| 02247446 | BETAMYCIN OPHTHALMIC/OTIC SOLUTION | STERIMAX INC | Solution | GENTAMICIN (GENTAMICIN SULFATE) 3 MG; BETAMETHASONE (BETAMETHASONE SODIUM PHOSPHATE) 1 MG | Cancelled Pre Market |
| 01989707 | CIDOMYCIN INJ 10MG/ML | HOECHST ROUSSEL CANADA INC. | Liquid | GENTAMICIN (GENTAMICIN SULFATE) 10 MG | Cancelled Post Market |
| 01989693 | CIDOMYCIN INJ 40MG/ML | HOECHST ROUSSEL CANADA INC. | Liquid | GENTAMICIN (GENTAMICIN SULFATE) 40 MG | Cancelled Post Market |
| 00259179 | CIDOMYCIN INJ 40MG/ML | ROUSSEL CANADA INC. | Liquid | GENTAMICIN (GENTAMICIN SULFATE) 40 MG | Cancelled Post Market |
| 00259160 | CIDOMYCIN INJ PEDIATRIC 10MG | ROUSSEL CANADA INC. | Liquid | GENTAMICIN (GENTAMICIN SULFATE) 10 MG | Cancelled Post Market |
| 00028371 | GARAMYCIN ONT 0.1% | SCHERING-PLOUGH CANADA INC | Ointment | GENTAMICIN (GENTAMICIN SULFATE) 1 MG | Cancelled Post Market |
| 00512192 | GARAMYCIN OPHTHALMIC DROPS 0.3% | MERCK CANADA INC | Drops | GENTAMICIN (GENTAMICIN SULFATE) 3 MG | Cancelled Post Market |
| 00028339 | GARAMYCIN OPHTHALMIC OINTMENT 0.3% | MERCK CANADA INC | Ointment | GENTAMICIN (GENTAMICIN SULFATE) 0.3 % | Cancelled Post Market |
| 00512184 | GARAMYCIN OTIC DROPS 0.3% | MERCK CANADA INC | Drops | GENTAMICIN (GENTAMICIN SULFATE) 3 MG | Cancelled Post Market |
| 00419028 | GARASOL INJECTABLE SOLUTION | SCHERING-PLOUGH CANADA INC | Solution | GENTAMICIN (GENTAMICIN SULFATE) 5 MG | Cancelled Post Market |
| 00587915 | GARASOL PIG PUMP | SCHERING-PLOUGH CANADA INC | Solution | GENTAMICIN (GENTAMICIN SULFATE) 4.35 MG | Cancelled Post Market |
| 02023822 | GENTAMICIN | PHARMA STULLN INC. | Solution | GENTAMICIN (GENTAMICIN SULFATE) 0.3 % | Cancelled Post Market |
| 01913530 | GENTAMICIN SULFATE IN 0.9% SODIUM CHLORIDE INJECTION | HOSPIRA HEALTHCARE ULC | Solution | GENTAMICIN (GENTAMICIN SULFATE) 0.8 MG; SODIUM CHLORIDE 9 MG | Cancelled Post Market |
| 01913565 | GENTAMICIN SULFATE IN NACL 0.9% INJ | HOSPIRA HEALTHCARE ULC | Solution | GENTAMICIN (GENTAMICIN SULFATE) 1 MG; SODIUM CHLORIDE 9 MG | Cancelled Post Market |
| 01913093 | GENTAMICIN SULFATE IN NACL 0.9% INJ | HOSPIRA HEALTHCARE ULC | Solution | GENTAMICIN (GENTAMICIN SULFATE) 1.2 MG; SODIUM CHLORIDE 9 MG | Cancelled Post Market |
| 01913549 | GENTAMICIN SULFATE IN NACL O.9% INJ | HOSPIRA HEALTHCARE ULC | Solution | GENTAMICIN (GENTAMICIN SULFATE) 0.8 MG; SODIUM CHLORIDE 9 MG | Cancelled Post Market |
| 02212927 | GENTAMICIN SULPHATE 0.3% - LIQ OPH | RIVEX OPHTHALMICS INC. | Liquid | GENTAMICIN (GENTAMICIN SULFATE) 3 MG | Cancelled Post Market |
| 02145731 | GENTAMICIN SULPHATE INJECTION USP-10MG/ML | NOVOPHARM LIMITED | Solution | GENTAMICIN (GENTAMICIN SULFATE) 10 MG | Cancelled Post Market |
| 02145758 | GENTAMICIN SULPHATE INJECTION USP-40MG/ML | NOVOPHARM LIMITED | Solution | GENTAMICIN (GENTAMICIN SULFATE) 40 MG | Cancelled Post Market |
| 02082144 | GENTAMICIN(E) 120MG LIQ IV 1.2MG/ML | BAXTER CORPORATION | Solution | GENTAMICIN (GENTAMICIN SULFATE) 1.2 MG | Cancelled Post Market |
| 00813974 | GENTASUL 100 INJECTION 100MG/ML | AYERST VETERINARY LABORATORIES | Liquid | GENTAMICIN (GENTAMICIN SULFATE) 100 MG | Cancelled Post Market |
| 00728349 | GENTASUL-50 INJ 50MG/ML | LANGFORD | Solution | GENTAMICIN (GENTAMICIN SULFATE) 50 MG | Cancelled Post Market |
| 00241636 | GENTOCIN | INTERVET CANADA CORP | Solution | GENTAMICIN (GENTAMICIN SULFATE) 3 MG | Cancelled Post Market |
| 00256536 | GENTOCIN DURAFILM | INTERVET CANADA CORP | Solution | GENTAMICIN (GENTAMICIN SULFATE) 3 MG; BETAMETHASONE ACETATE 1 MG | Cancelled Post Market |
| 00288179 | GENTOCIN INJECTABLE SOLUTION 50MG/ML | SCHERING-PLOUGH CANADA INC | Solution | GENTAMICIN (GENTAMICIN SULFATE) 50 MG | Cancelled Post Market |
| 00392332 | GENTOCIN INTRAUTERINE SOLUTION 10MG/ML | SCHERING-PLOUGH CANADA INC | Solution | GENTAMICIN (GENTAMICIN SULFATE) 10 MG | Cancelled Post Market |
| 00256544 | GENTOCIN OTIC SOLUTION | SCHERING-PLOUGH CANADA INC | Solution | GENTAMICIN (GENTAMICIN SULFATE) 3 MG; BETAMETHASONE (BETAMETHASONE VALERATE) 1 MG | Cancelled Post Market |
| 00573787 | GENTOCIN SPRAY 1.1MG/ML | SCHERING-PLOUGH CANADA INC | Spray | GENTAMICIN (GENTAMICIN SULFATE) 1.1 MG | Cancelled Post Market |
| 00872873 | PMS-GENTAMICIN CREAM 1MG/GM | PHARMASCIENCE INC | Cream | GENTAMICIN (GENTAMICIN SULFATE) 1 MG | Cancelled Post Market |
| 00872881 | PMS-GENTAMICIN OINTMENT 1MG/GM | PHARMASCIENCE INC | Ointment | GENTAMICIN (GENTAMICIN SULFATE) 1 MG | Cancelled Post Market |
| 02237689 | PMS-GENTAMICIN OPHTHALMIC OINTMENT 0.3% | PHARMASCIENCE INC | Ointment | GENTAMICIN (GENTAMICIN SULFATE) 0.3 % | Cancelled Pre Market |
| 02230889 | PMS-GENTAMICIN OTIC DROPS 0.3% | PHARMASCIENCE INC | Drops | GENTAMICIN (GENTAMICIN SULFATE) 3 MG | Cancelled Post Market |
| 00776521 | PMS-GENTAMICIN SULFATE OPH DPS 0.3% | PHARMASCIENCE INC | Drops | GENTAMICIN (GENTAMICIN SULFATE) 3 MG | Cancelled Post Market |
| 01933299 | R.O.-GENTYCIN | RICHMOND PHARMACEUTICALS INC. | Liquid | GENTAMICIN (GENTAMICIN SULFATE) 3 MG | Cancelled Post Market |
| 00805386 | RATIO-GENTAMICIN | RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | Cream | GENTAMICIN (GENTAMICIN SULFATE) 0.1 % | Cancelled Post Market |
| 02229441 | SANDOZ GENTAMICIN | SANDOZ CANADA INCORPORATED | Solution | GENTAMICIN (GENTAMICIN SULFATE) 3 MG | Cancelled Post Market |
| 02230888 | SANDOZ GENTAMICIN | SANDOZ CANADA INCORPORATED | Ointment | GENTAMICIN (GENTAMICIN SULFATE) 3 MG | Cancelled Post Market |
| 02244999 | SANDOZ PENTASONE | SANDOZ CANADA INCORPORATED | Solution | GENTAMICIN (GENTAMICIN SULFATE) 3 MG; BETAMETHASONE (BETAMETHASONE SODIUM PHOSPHATE) 1 MG | Cancelled Post Market |
| 00646350 | SEPTOPAL | BIOMET ORTHOPEDICS, INC. | Implant | GENTAMICIN (GENTAMICIN SULFATE) 4.5 MG | Cancelled Post Market |
| 00489905 | TOPAGEN ONT | SCHERING-PLOUGH CANADA INC | Ointment | GENTAMICIN (GENTAMICIN SULFATE) 5.25 MG; BETAMETHASONE (BETAMETHASONE VALERATE) 1.335 MG | Cancelled Post Market |